ELUT (Elutia) Net Profit

Official company branding of Elutia (ELUT)

Elutia Inc. (ELUT) minimizes operational risks through the production of biomatrices for cardiology and aesthetics. The company's total profit demonstrates financial stability, with the indicator holding around -0.03. The issuer dominates regenerative medicine by creating CanGaroo antibacterial wraps for tissue protection. The brand's flawless image is confirmed by high physician confidence in the safety of its innovative pacemaker coatings.

ELUT: Elutia Corporation Net Income 02/21/2024 - 10/30/2026

Analytical breakdowns and data insights for company Elutia (ELUT)

- price and consensus price forecast:
Stock Quotes Elutia Corporation|ELUT - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Elutia Corporation|ELUT - Total Company Value
- book capitalization data:
Net Assets per Single Share Elutia|ELUT - Company Net Assets|Market Value to Book Value elutia.com|ELUT - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Elutia Inc.|ELUT - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Elutia Inc|ELUT - Company Debts|Debts to Net Assets Elutia Corporation|ELUT - Company Long-Term Liabilities|Amount of Current Liabilities Elutia|Intermediate Coverage Ratio elutia.com
- earnings and valuation multiples information:
ELUT - Net Income
Basic company analysis:ELUT - Elutia Corporation
Mass-produced product of Elutia Corporation

This indicator reflects the aggregate market consensus regarding the company's daily net benefit, capturing the sensitivity of fundamental value to operating margin dynamics. Analyzing the financial performance history of Elutia Inc. (ELUT), an investor will see how marketing and compliance costs, coupled with the slow implementation of EluPRO biomatrices, create pressure on capital, transforming current losses into risks of a long-term price drawdown.

Key competitors

Net Income Intuitive Corp|DHR (Danaher Corp.) - Net Profit|Net Profit bd.com|Company Net Income STERIS (STE)|Company Net Income WST (West Pharma)|Baxter Corp - Net Income|Final Profit MASI|Stevanato Group S.p.A. - Net Profit|Net Financial Result teleflex.com TFX|Merit Medical (MMSI) - Company Net Income|Company Profit NVST|Company Net Income ICU Medical Corp|Sirona Dental Systems (XRAY) - Net Financial Result|Net Income LMAT (LeMaitre Vascular, Inc.)|Profit After Payment of Taxes ATRC|Company Net Income STAAR Surgical STAA|Final Profit NAGE|ZIMV: Net Income|ANGO - Net Profit|Cerus Corporation (CERS) - Company Net Income|Net Income teknova.com|MGRM (Monogram Orthopedics) - Net Profit|Company Net Income Sharps Tech STSS|Company Net Income InfuSystem Holdings (INFU)|Utah Med - Company Profit|KORU Medical - Net Income|Profit After Payment of Taxes NYXH (nyxoah.com)|MBOT - Company Net Income|Net Financial Result Pro-Dex Inc PDEX|ZTEK: Net Profit|Company Net Income Milestone Scientific Corporation (MLSS)|Company Net Income NEXGEL, Inc.|Company Net Income RVP|Net Income HBIO (Harvard Bioscience, Inc.)|Net Profit Femasys Inc (FEMY)|Meihua Medical Technologies Co., Ltd. - Net Income|Profit After Payment of Taxes POAI (Predictive Oncology Inc)|Callan JMB Corp - Net Profit|Net Financial Result atrioncorp.com ATRI|NURO: Net Profit